ClinicalTrials.Veeva

Menu

Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels (TdBTS)

U

Universitas Negeri Semarang

Status

Completed

Conditions

Heart Arrest
Inflammatory Response
Sport Injury
Oxidative Stress

Treatments

Other: 140kms cycling

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017

Full description

Eligible Criteria:

  1. minimum sample size of 80 men, non-athlete, participants of TdB
  2. Classified into two groups: 160kms cycling and 100kms cycling participation
  3. 25-55 years old
  4. voluntary participate in the research
  5. eligible in pre participatory physical examination and ECG test by the doctor
  6. have no history of the previous acute coronary syndrome (ACS)

Measurements:

Interview for determining predictors of sports participation history, medical history, family medical history and Rate of Perceived Exertion Measurement and examination to determine: anthropometry parameters, clinical conditions (Systolic BP, Diastolic BP, hemoglobin levels, T-cholesterol and HDL-C levels, the intensity in cycling activities (mileage, velocity, duration, and time for resting), hemodynamic responses (average and maximum heart rate, Karvonen Index), and Hydration status

Other outcome measurements; pre and post-TdB 2017 measurements of cTnI, MDA, and hs-CRP

Enrollment

94 patients

Sex

Male

Ages

25 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • minimum sample size of 80 men, non athlete, participants of TdB
  • Classified into two groups: 160kms cycling and 100kms cycling participation
  • 25-55 years old
  • voluntary participate in the research
  • eligible in pre participatory physical examination and ECG test by doctor have no history of previous acute coronary syndrome (ACS)

Exclusion criteria

  • stop cycling before finish line due to mechanical or bicycle related errors
  • (subjects who stop cycling due to any physical symptoms and health related problem included in analysis)

Trial design

94 participants in 3 patient groups

Group 140kms cycling
Description:
Participants of Tour de Borobudur 2017 140 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Treatment:
Other: 140kms cycling
Group 100kms cycling
Description:
Participants of Tour de Borobudur 2017 100 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Treatment:
Other: 140kms cycling
Group 240kms cycling
Description:
Participants of North Coast 2017 240 km cycling touring and willing to participate in the study. Investigator did not give any intervention, just observed the cycling touring event that the subjects participated
Treatment:
Other: 140kms cycling

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems